Correlation Between Takeda Pharmaceutical and Psyence Biomedical
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Takeda Pharmaceutical and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Psyence Biomedical.
Diversification Opportunities for Takeda Pharmaceutical and Psyence Biomedical
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Takeda and Psyence is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Psyence Biomedical go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Psyence Biomedical
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.1 times more return on investment than Psyence Biomedical. However, Takeda Pharmaceutical Co is 10.45 times less risky than Psyence Biomedical. It trades about -0.11 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.29 per unit of risk. If you would invest 1,458 in Takeda Pharmaceutical Co on September 2, 2024 and sell it today you would lose (96.00) from holding Takeda Pharmaceutical Co or give up 6.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Psyence Biomedical Ltd
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Psyence Biomedical |
Takeda Pharmaceutical and Psyence Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Psyence Biomedical
The main advantage of trading using opposite Takeda Pharmaceutical and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
| Psyence Biomedical vs. Zedge Inc | Psyence Biomedical vs. MagnaChip Semiconductor | Psyence Biomedical vs. Everspin Technologies | Psyence Biomedical vs. Valens |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |